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Background: At later stages of folliculogenesis, the mammalian ovarian follicle contains layers of epithelial
granulosa cells surrounding an antral cavity. During follicle development granulosa cells replicate, secrete hormones
and support the growth of the oocyte. In cattle, the follicle needs to grow > 10 mm in diameter to allow an oocyte
to ovulate, following which the granulosa cells cease dividing and differentiate into the specialised cells of the
corpus luteum. To better understand the molecular basis of follicular growth and granulosa cell maturation, we
undertook transcriptome profiling of granulosa cells from small (< 5 mm; n = 10) and large (> 10 mm, n = 4)
healthy bovine follicles using Affymetrix microarrays (24,128 probe sets).
Results: Principal component analysis for the first two components and hierarchical clustering showed clustering
into two groups, small and large, with the former being more heterogeneous. Size-frequency distributions of the
coefficient of variation of the signal intensities of each probe set also revealed that small follicles were more
heterogeneous than the large. IPA and GO enrichment analyses revealed that processes of axonal guidance,
immune signalling and cell rearrangement were most affected in large follicles. The most important networks were
associated with: (A) Notch, SLIT/ROBO and PI3K signalling, and (B) ITGB5 and extracellular matrix signalling through
extracellular signal related kinases (ERKs). Upstream regulator genes which were predicted to be active in large
follicles included STAT and XBP1. By comparison, developmental processes such as those stimulated by KIT, IHH and
MEST were most active in small follicles. MGEA5 was identified as an upstream regulator in small follicles. It encodes
an enzyme that modifies the activity of many target proteins, including those involved in energy sensing, by
removal of N-acetylglucosamine from serine and threonine residues.
Conclusions: Our data suggest that as follicles enlarge more genes and/or pathways are activated than are
inactivated, and gene expression becomes more uniform. These findings could be interpreted that either the cells
in large follicles are more uniform in their gene expression, or that follicles are more uniform or a combination of
both and that additional factors, such as LH, are additionally controlling the granulosa cells.
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An ovarian primordial follicle is composed of an inactive
oocyte surrounded by granulosa cells all enclosed by a
basal lamina. Once activated the follicle grows by enlarge-
ment of the oocyte and replication of the granulosa cells
from about 24 cells to 50 million cells in the cow [1]. Dur-
ing growth, a fluid-filled antrum or cavity also develops in
the middle of the follicle [2] and bovine follicles need to
enlarge to over 10 mm in diameter, principally by antrum
expansion, to be capable of ovulation. Ovulation occurs
only once per oestrous cycle. However, instead of one
primordial follicle growing to the necessary size and then
ovulating, many follicles commence growth during the
course of the cycle. The vast majority of these growing fol-
licles become atretic leaving in cows only one, or occa-
sionally two, follicles to ovulate. The process of follicle
growth during a cycle is not random either, since two or
three groups or waves of follicles emerge from a pool of
follicles of approximately 5 mm in diameter during each
oestrous cycle [3,4]. During these maturational waves, fol-
licles continue to enlarge over several days until one fol-
licle that is growing faster and is hence larger than the
others gains dominance [5,6]. Thus a deviation in the size
of follicles occurs when they are around 7–8 mm in diam-
eter [7]. As the larger dominant follicle continues to ex-
pand further, the smaller follicles in the wave undergo
atresia. If the wave is at the end of a cycle the dominant
follicle ovulates and a new cycle is initiated. In earlier
waves the dominant follicle also eventually undergoes atre-
sia and another wave then ensues.
During growth of the follicle, the granulosa cells undergo
a number of maturational changes. Early in follicle devel-
opment they secrete the hormone inhibin and later at
the pre-ovulatory sizes, oestradiol. The cells also ex-
press follicle-stimulating hormone receptors soon after
follicle activation and then during the course of domin-
ance they additionally express luteinising hormone re-
ceptors (LHCGR). The process of dominance is not well
understood largely because it is not possible to trace the
cellular changes that occur within a follicle in real time
in order to relate the events preceding development to
future outcomes, such as predicting whether an individ-
ual follicle will become dominant or subordinate. An-
other recent approach compared identical-sized follicles
before deviation into dominant and subordinate follicles
and analysed gene expression [8]. In that study a firm
hypothesis was investigated and it was found that folli-
cles with the highest level of CYP11A1, encoding the
rate limiting enzyme for progesterone synthesis, also
had the highest level of CYP19A1, encoding the rate-
limiting enzyme for oestradiol synthesis [8]. It also had
the highest expression level of three genes (LAMB2,
COL4A1, HSPG2), encoding components of an unusual
basal lamina matrix, focimatrix (abbreviated from focalintra-epithelial matrix) [8]. It was concluded that since
these five genes continue to be further up regulated in
dominant and preovulatory-size follicles and because the
expression levels of these genes were correlated with each
other, that focimatrix production and CYP11A1 expression
might be important in a follicle gaining dominance [8].
Focimatrix develops as aggregates of basal lamina material
deposited between the granulosa cells and contains the α1
and α2 chains of collagen type IV, laminin α1, β2 and γ1
chains, nidogen-1 and −2, perlecan, collagen type XVIII and
usherin, but not versican [9]. These components are similar
to those found in the follicular basal lamina at the stage of
follicular development when focimatrix is first observed
[10,11]. Focimatrix initially appears in bovine follicles greater
than 5 mm in diameter, and the amount of focimatrix in-
creases with increasing follicular size [9]. This first appear-
ance of focimatrix occurs as follicles emerge in a growth
wave, and prior to emergence of the dominant follicle.
The aim of this study, therefore, was to identify the
important processes occurring at the key stages of antral
follicle development at the time 1) prior to follicles en-
tering a wave and 2) prior to ovulation, by gene expres-
sion array profiling. In order to gain a greater knowledge
of the mechanisms responsible for granulosa cell matur-
ation and selection of dominant follicles there have been
several transcriptome analyses of bovine granulosa cells
[12-17]. Evans and colleagues [12] examined dominant
and subordinate follicles (some of which were atretic) by
two-color hybridisation on a self -generated array contain-
ing approximately 1,300 putative genes. Serial Analysis of
Gene Expression (SAGE) tags were examined in follicles
of a larger size (8 mm) around the time of deviation for se-
lection of the dominant follicle [13]. Skinner et al. [14] iso-
lated healthy antral follicles at three different sizes, and
used pooled follicle RNA to hybridise to individual arrays.
Liu et al. [15] was also interested in selection of the dom-
inant follicle using a two color array, but did not separate
the granulosa and thecal compartments for analysis. Sub-
ordinate, dominant and preovulatory follicles have also
been examined by RNA-seq and the effects of lactation ex-
amined on gene expression pathways [16]. More recently,
Christenson et al. [17] also used microarray analysis to in-
vestigate gene expression in bovine antral follicles before
and after the LH surge. Only in one of these studies were
comparisons made between small follicles, less than 5 mm
in diameter, and larger follicles, but the analysis may have
been compromised by a lack of statistical power (n = 2/
group). Smaller follicles represent those before focimatrix
is expressed and before follicles have entered a wave.
Hence we chose to compare these smaller follicles with
larger preovulatory-size follicles; all of which were vali-
dated as healthy. Additionally we ensured that the isolated
granulosa cells were devoid of any potentially contaminat-
ing theca cells.
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Selection of follicles for analyses
To ensure accurate comparisons were made between
granulosa cells from small (3.2 ± SEM 0.2 mm in diameter;
n = 10) versus large (15.3 ± 0.6 mm; n = 4) follicles, only
antral follicles of healthy morphology [18,19] were se-
lected for this study. Confirmation of health stage was also
performed on large follicles showing CYP19A1 expression
assessed by qRT-PCR similar to that observed in healthy
large follicles using microarray analysis (Figure 1) [20]. To
ensure that the isolated granulosa cells were not contami-
nated with any thecal cells the level of CYP17A1 was mea-
sured. CYP17A1 is expressed exclusively in thecal cells
[21]. No follicles with more than 1% level of expression of
CYP17A1 found in thecal samples were included in the
analysis. Since there were some low yields of RNA, three
of the samples of small follicles were pools of two follicles,
each from the same animal.
Validation of microarray data
To confirm changes in the expression of genes identi-
fied by microarray analysis, quantitative RT-PCR ana-
lyses of CYP19A1 were performed on the same samples.
Similar to that observed in microarray analysis, the ex-
pression of CYP19A1 was significantly increased in
granulosa cells isolated from large follicles compared to
granulosa cells isolated from small follicles (Figure 1).
The microarray analyses also identified genes well known
to be up regulated across the sizes of follicles examined.
Some examples of these include hormone-related genes
CYP11A1 (increased 5.8 fold), HSD3B1 (6.0 fold), LHCGR
(8.8 fold) and INHBA (3.8 fold) and focimatrix genes
COL4A1 (6.8 fold) and LAMA1 (5.8 fold) as shown previ-
ously [20,22] (Table 1).
Statistical analyses of gene expression
Granulosa from small healthy follicles were from one of
two groups having either columnar (n = 5) or rounded
(n = 5) shaped basally-situated granulosa cells as describedFigure 1 Quantitative RT-PCR analysis of CYP19 expression (A) compa
(B). Mean ± SEM expression of CYP19 was determined in granulosa cells de
(blue columns) used for the microarray analysis. Microarray signal data werin the Methods. Principal component analysis (PCA) for
the first three components (Figure 2) and hierarchical
clustering (Additional file 1: Figure S1) for the total num-
ber of probe sets (n = 24,182) of all arrays in this study
was conducted. Neither of these unsupervised analytical
methods separated the small healthy follicle arrays into
the rounded and columnar groups, and in fact no genes
were shown to be more than 2-fold differentially expressed
between the two subgroups with a Benjamini-Hochberg
False Discovery Rate (FDR) of P < 0.05 by ANOVA. There-
fore, the small healthy follicles were treated as a single
group for further analyses (n = 10) and compared with the
group of large follicles (n = 4). It can be clearly seen that
the large follicles clustered comparatively closely together
and differed from the small healthy follicles, which ap-
peared to be more variable across the group. This was also
reflected in the hierarchical clustering analysis (Additional
file 1: Figure S1). Seven hundred and fifty eight probe sets
were found to be differentially expressed between small
and large follicles, when a P < 0.05 and an arbitrary thresh-
old of 3-fold minimum differential expression was applied
(Table 2). These consisted of 579 up-regulated and 179
down-regulated probe sets in large with respect to small
follicles. The fact that substantially more genes were up
regulated than down regulated in large healthy follicles,
could indicate that activation rather than a reduction in
additional pathways occurs as follicles enlarge.
Variability of gene expression
The Coefficient of Variation (SD/Mean X 100 = CV) for
each gene in small and in large follicles in both the
complete probe set and the >2-fold differentially regulated
probe set were calculated. The CV-frequency distribution
plots are shown in Figure 3. The small follicles (Figure 3A)
had more genes that were variably expressed, particularly
for the genes whose expression was >2-fold differentially
regulated between small and large follicles (Figure 3B).
Furthermore, when we repeated the analysis using only
the genes whose signal intensities were in the top 50% onred with gene induction profiles observed by microarray analysis
rived from the 10 small (clear columns) and 4 large follicles
e non-log transformed and divided by 104.
Table 1 Genes which are up regulated in large follicles with respect to small follicles†
Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change
Cell cycle
RASA2 5.5 TACC1 3.5 RAD50 3.1
TBCEL 4.8 TOPORS 3.3 HELZ 3.1
CDK13 4.3 TRIB2 3.2
TPR 4.3 ANAPC5 3.1
Cell morphology
LIMA1 8.2 FERMT2 4.2 ARPC1B 3.3
SLMAP 5.1 TTLL3 3.9
MYO1B 5.1 ABLIM1 3.7
Cytokines, hormones and receptors
IFI30 39.0 F2RL1 5.3 THBS3 3.5
PTHLH 12.8 DKK3 5.3 IGFBP6 3.5
F2R 8.9 NPR3 5.2 BMPR2 3.3
LHCGR 8.8 LPHN2 4.7 BAI2 3.3
IGFBP4 7.3 PGR 4.7 GPR88 3.2
F3 7.2 TNFAIP8L3 4.7 SCG2 3.2
OPTN 6.5 GABARAPL1 4.6 OSBPL8 3.1
IL4R 6.2 STRA6 4.2 TM2D1 3.1
IL6R 5.7 RYK 4.2 BMPR1A 3.1
GRK5 5.6 INHBA 3.8 NRP1 3.0
NR5A2 5.5 LGALS3BP 3.5 GPR173 3.0
PTGFR 5.5
Directional cell growth
LRP8 53.6 SLITRK2 5.1 SEMA6A 3.3
EFNA5 8.6 PLXNC1 4.8 NINJ1 3.2
MPP5 7.1 PLXNB2 4.7 ROBO1 3.1
ROBO2 6.7 *EPHB6 3.8 ROCK1 3.1
SEMA6D 6.2 COLEC11 3.5
Extracellular matrix and synthesis
TNFAIP6 279.6 COL16A1 6.0 VCAN 5.0
SPOCK2 22.0 LAMA1 5.8 LEPREL1 4.9
COL4A1 6.8 PCOLCE 5.7 SDC2 3.8
Intercellular and cell to matrix adhesion
ARHGAP18 20.5 CDH11 4.6 TSPAN9 3.4
ITGB5 11.4 *BST2 4.4 PARD3B 3.2
VCAM1 7.3 TNS3 3.6 TSPAN2 3.0





HSP90AA1 7.0 SH3GL2 4.1 RAB7A 3.3
TMEM27 5.1 SCYL2 4.0 CLGN 3.2
GOLGA4 4.6 MLEC 3.8 CLTC 3.2
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Table 1 Genes which are up regulated in large follicles with respect to small follicles† (Continued)
TMEM47 4.5 PLEKHG1 3.6 FKBP9 3.1
PLEKHA2 4.2 PLEKHB2 3.5 CANX 3.1
PLEKHH3 4.1 GDI1 3.4
Proteolysis or inhibition
PRSS23 48.5 ADAMTS4 4.7 FBXL20 3.9
PLAT 17.5 HM13 4.5 ADAM10 3.7
ACE2 12.9 RNF128 4.5 MYCBP2 3.4
CPD 11.8 CTSB 4.4 HERPUD1 3.3
SERPINA5 11.2 SPG7 4.2 RNF20 3.3
ECE1 9.5 DERL1 4.1 UBR3 3.2
ADAM9 8.4 USP4 4.0 MARCH5 3.2
TIMP2 7.9 UBR1 4.0 FAF2 3.2
ADAM12 6.6 MARCH6 3.9 TTC3 3.1
USP7 6.4
RNA processing
NOL3 6.0 PBRM1 4.3 LUC7L3 3.8
CPEB4 5.1 PRPF38B 4.2 PNISR 3.7
UTP6 4.8 RBM5 4.0 SYNCRIP 3.6
CSDE1 4.7 TIA1 3.9 RNASEK 3.6
CHD1 4.7 CTR9 3.9 DDX46 3.4
SF3B1 4.6 HNRPLL 3.9 DICER1 3.1
RBM25 4.4
Transcription regulation
TOX 11.4 ZNF317 3.8 BRWD1 3.3
NMI 8.4 HUWE1 3.8 NOSTRIN 3.2
NOTCH1 8.4 TRIM25 3.7 JARID2 3.2
TOB1 6.3 CREB3L2 3.7 ZNF462 3.1
ZNF292 6.0 ADNP 3.7 ANKRD10 3.1
MTPN 5.7 ZNF609 3.6 CITED2 3.1
AFF1 5.5 KLF6 3.5 MED24 3.1
FOXP2 5.3 *MLL3 3.5 GPS2 3.1
ID2 4.5 NCOR1 3.5 HMGXB3 3.1
ID3 4.3 RBFOX2 3.4 TFCP2 3.1
*SON 4.2 ZNF24 3.3 CITED1 3.1
WHSC1L1 3.9
Translation regulation
EIF4G3 7.4 BZW2 3.6 EIF2C2 3.3
EIF4EBP1 7.3 EIF2C3 3.4
BZW1 4.2 IREB2 3.4
Transport
SLC5A11 15.6 MAL2 3.8 SEC63 3.4
APOA2 12.5 CLIC4 3.7 STAR 3.4
SLC39A8 9.1 CPNE8 3.7 TFR2 3.3
AP2B1 6.8 ATP13A3 3.6 COPZ1 3.3
SLC25A28 5.8 SLC25A12 3.6 MICU1 3.2
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Table 1 Genes which are up regulated in large follicles with respect to small follicles† (Continued)
SLC27A3 5.7 SLC26A11 3.6 NUP85 3.2
TNPO1 5.5 AP3S2 3.6 CYCS 3.2
SLC40A1 5.3 TM9SF4 3.5 APOA1 3.2
ABCB1 5.1 AP1S2 3.5 CLTC 3.2
ATP6V1A 4.3 ACBD5 3.5 STBD1 3.1
RRBP1 4.2
Other enzymes
ME3 26.7 PTPN13 4.2 GPX3 3.2
CYBB 18.1 SCD5 4.2 PDP1 3.2
CYP19A1 14.2 FDFT1 4.1 LARGE 3.2
NT5E 12.8 UGCG 4.0 MLL5 3.2
RGN 9.8 DPYSL2 3.8 EDEM2 3.1
PYGL 8.9 PLD1 3.7 NCEH1 3.1
B3GALT2 6.5 PPAP2B 3.7 XRN2 3.1
PDSS1 6.0 TET2 3.7 RDH11 3.1
HSD3B2 6.0 PFKM 3.7 CHST10 3.1
PPM1K 5.9 SGSH 3.6 PTP4A2 3.1
CYP11A1 5.8 CUL3 3.5 PTPN11 3.1
PIGS 5.5 QSOX1 3.5 MAOA 3.1
IDH3A 5.5 ACSS2 3.5 CA8 3.0
CMAHP 4.6 DPYD 3.4 HECTD1 3.0
PDPK1 4.5 MTR 3.4 PPP2R5E 3.0
AHCYL2 4.4 POR 3.3 CUL1 3.0
Other signalling
BEX2 9.0 ARHGEF3 4.8 *PRKAG2 3.4
PIK3R1 9.0 AMIGO2 4.7 SNTB2 3.4
DTNA 8.5 MAP2K4 4.4 GLG1 3.3
DACT1 8.4 NDRG3 4.4 GNA11 3.3
ARFGAP3 7.6 APC 4.0 IER3 3.3
GADD45B 6.8 PDCD4 4.0 NISCH 3.3
NDRG4 6.7 BMP2K 3.8 INSIG2 3.2
BCAS3 6.0 Ifi27l1 3.7 STIM1 3.2
MIA3 5.4 ERRFI1 3.6 BCL2L2 3.2
MS4A8B 5.3 ARHGEF6 3.5 PIP4K2A 3.1
SAFB2 4.9 FICD 3.4 KIRREL 3.0
MAPK6 4.8
Other
FAM114A1 18.8 TMEM176A 4.1 ANKRD12 3.4
DDX26B 9.7 WDFY4 3.9 *WDFY2 3.4
LHFPL2 6.8 PSMD4 3.8 CHCHD10 3.3
RNF213 5.9 RHBDD2 3.8 MRAP 3.3
OBSL1 5.8 *ZNF317 3.8 TMEM50B 3.2
USHBP1 5.2 TMEM176B 3.7 BRWD3 3.2
RSRC2 5.1 PSAP 3.7 *OXR1 3.2
KLHL28 5.0 LRIG3 3.7 HIATL1 3.1
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Table 1 Genes which are up regulated in large follicles with respect to small follicles† (Continued)
LINGO2 5.0 AKAP8L 3.6 MGARP 3.1
PDLIM4 5.0 FAM126B 3.6 PHF3 3.1
ODF2L 4.4 RCN3 3.6 MPV17L2 3.1
BTBD7 4.3 LRRC2 3.6 TBC1D5 3.0
RNF144B 4.3 SUSD4 3.5 Gm16462/ 3.0
R3HCC1 4.2 UHRF1BP1L 3.5 Gm8787
TXNIP 4.1 YPEL5 3.5 VWA1 3.0
RCAN3 4.1 FAM174B 3.4 ZBTB33 3.0
†(≥3 fold, P < 0.05) and categorised by function. Genes are listed in descending order of fold change within each category. Significance was determined by
Benjamini-Hochberg post-hoc test for multiple corrections following one way ANOVA.
*indicates genes determined from the Partek analysis based on the Affymetrix annotations which were not assigned identities by IPA.
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thus demonstrating that this property is inherent in the
small follicles rather than possibly due to overall lower
array intensities (Additional file 2: Figure S2). The higher
variability in gene expression in the small follicle granulosa
cells indicates that either the cells in small follicles were less
uniform in their gene expression, or that small follicles were
less uniform or a combination of both. The more variably
expressed genes were up regulated during follicle enlarge-
ment which indicates that the reduction in variability ofFigure 2 Unsupervised principal component analysis (PCA) of
arrays for small (n = 5 rounded phenotypes in yellow and n = 5
columnar phenotypes in blue) and large (n = 4, in green)
follicles in Partek. The graph is a scatter plot of the values for the
first (X) and second (Y) principal components based on the
correlation matrix of the total normalised array intensity data.gene expression and their up regulation are potentially both
important processes in follicle maturation.
Differentially expressed genes
A list of genes which were differentially regulated between
small and large healthy follicles (758 probe sets, 3-fold dif-
ferentially expressed, P < 0.05, gene list and names are
shown in Additional file 3: Table S1) was examined in de-
tail. We were able to identify genes which were well char-
acterised during follicle development, and known to be
differentially regulated between small and large follicles in
our microarray analyses which included LHCGR [23], pro-
gesterone receptor [24], INHBA [25] and the receptor for
the lipid mediator prostaglandin F2α (PTGFR) [26]. In the
list 533 probe sets could be assigned gene identities in In-
genuity Pathway Analysis (IPA) which included those with
homology to multiple probe sets, consisting of 446 anno-
tated genes, of these 352 were up regulated in large folli-
cles (Table 1) and 92 were down regulated (Table 3). This
list was also uploaded to the Gene Ontology Enrichment
Analysis Software Toolkit (GOEAST) program.
Pathway and network analyses
The top ten canonical pathways generated in IPA and sig-
nificant GO terms indicate a trend toward directional cell
growth and extracellular signalling. In particular, the three
most significantly associated IPA canonical pathways are
axonal guidance (Additional file 4: Figure S3), Ephrin A
and Rho GTPase signalling, which are associated with cell
attachment and cytoskeletal rearrangement (Figure 4A). TheTable 2 Numbers of probe sets 2 fold or more
differentially expressed in large healthy follicles with
respect to small healthy follicles*
Fold change Up-regulated Down-regulated Total
> 2 1666 1048 2714
> 3 579 179 758
> 4 278 67 345
*Significant by FDR with P < 0.05, with ANOVA in Partek using the step-up
Benjamini-Hochberg FDR method for multiple corrections.
Figure 3 Plots of coefficients of variation (CV) versus their
frequency for granulosa cell cDNA hybridised to Bovine
Genome Affymetrix Expression arrays across replicate samples
per gene for small (n = 10) in A and large follicles (n = 4) in B.
All genes include all the probe sets present on the array (n = 24,128 ).
2 fold and 3 fold represent all probe sets which were 2-fold (n = 2,780)
or 3-fold (n = 760) differentially regulated between small and large
follicles in Partek.
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ated with inflammation and acute phase reaction, also con-
tains a number of genes which were activated in large
follicles including IL6R, JNK, PIK3R and TSG6 (or TNFAIP6,
already mentioned). The GO terms enriched for the large to
small follicle comparison are also connected with inflamma-
tion signalling and cell rearrangement (Figure 4B).
The two top networks generated by IPA based on the
dataset above are shown in Figure 5. The network in
Figure 5A shows an emphasis on cytoplasmic mem-
brane receptor signalling centred around Notch and the
ADAM protease genes and axonal guidance through the
ROBO genes and LRP8. There is also considerableconnectivity associated with PI3K which exerts direct ef-
fects on the cytoskeleton and indirectly protein translation
via EI4EBP1. The other network (Figure 5B) indicates sig-
nificant interaction with extracellular matrix by LAMA1,
LAMC2 and COL4A1 which appear to mainly signal
through the cell surface components ITGB5, CSPG4 and
CDH11 to ERK pathways. This extracellular matrix path-
way is probably that associated with focimatrix production
that develops as follicles enlarge from 5 to 10 mm in
diameter [9,27].Genes activated in large versus small follicles
TGF-β signalling
It is well known that TGF-β signalling plays an important
role in follicular development, as reviewed by Knight and
Glister in 2006 [28] and more recently by Myers and
Pangas in 2010 [29]. In our study, three members of the
TGF-β superfamily, INHBA which helps drive androgen
production from the theca [30] and inhibits production of
FSH by the pituitary [31], and the bone morphogenetic
protein receptor genes BMPR1A and BMPR2, were up
regulated in large follicles (Table 1). The BMP receptor
type II binds GDF-9 and BMP-15, two critical growth fac-
tors for granulosa cells which are secreted by the oocyte at
antral stages [32]. The activation of these genes probably
contributes to follicle growth during the latter antral
stages when androgen production is increased and com-
bines with LH to maintain high oestradiol levels following
the reduction in circulating levels of FSH when a domin-
ant follicle emerges.
Immune/Inflammation signalling
The immunoregulatory receptor genes, IL4R IL6R and
IL20RA and the thrombin and thrombin-like receptors
F2R and F2RL1were also identified among the list of
genes activated in large follicles (Table 1). Bovine gran-
ulosa cells have been shown to be capable of initiating
an inflammatory response to lipopolysaccharide with
increased expression of IL-6 and IL-8 [33]. Addition-
ally, IL-6 and its receptor have been studied in relation
to cumulus-oocyte complex development, where they
are known to play an active role in expansion and ovu-
lation [34]. The expression of another inflammatory
cytokine IL-4 and its receptor have been shown to
increase in the rat preovulatory follicle [35]. Interest-
ingly, thrombin receptor RNA expression has pre-
viously been reported to be lower in larger follicles
than small [36] as opposed to our study, though the
health of the follicles was unclear in the other study.
These inflammatory pathways identified as significant
in our analysis further confirm that significant signal-
ling through these pathways occurs in the later stages
of bovine antral follicle development.
Table 3 Genes which are down regulated in large follicles with respect to small follicles†




JAKMIP1 20.8 MYO10 6.8 ACTA1 3.4
SEPT4 15.3 MFAP2 4.6 MYO1D 3.0
Cytokines, hormones and receptors
KIT 23.1 IL33 3.6 GPR77 3.2
ANGPT2 11.5 PTPRN2 3.6 ANGPTL2 3.1
RYR2 7.0 SHISA2 3.5 F2RL2 3.1
PDGFC 4.6 CMTM8 3.4 SFRP4 3.0
FGFR2 3.7 IL20RA 3.4
Directional cell growth
FEZ1 3.8 EPHA1 3.2
Extracellular matrix and synthesis
LAMC2 3.4 COL1A1 3.0
Intercellular and cell to matrix adhesion
NEDD9 5.9 CDH2 4.0 NPNT 3.2
Protein trafficking
SNX31 6.0 ADCK3 3.4 MZB1 3.1
CLU 4.9
Proteolysis and inhibition
*PTI 5.6 LTF 4.0 EPHX1 3.4




MYC 16.4 FOS 4.0 EMX2 3.1
HOPX 13.8 FHL2 3.3 MSX1 3.1
TGIF1 6.1 HES1 3.2
Transport
SVOPL 8.6 NUP210 4.7 AQP1 3.2
NALCN 6.0 ABCC8 4.7 FXYD6 3.2
AP3B2 5.5 STARD10 3.4 ZP3 3.2
Other enzymes
GATM 11.1 MAN1A1 4.2 PTGS2 3.5
CA14 8.8 ENPP1 4.1 ABAT 3.5
PAPSS2 7.8 HMOX1 4.1 PFKFB3 3.2
RASL11B 6.8 PHGDH 3.7 CYP2C19 3.1
GALNT13 5.3 RENBP 3.6 AKR1C3 3.1
AKR1B1 4.5 DDO 3.6 GYLTL1B 3.0
Other signalling
MEST 28.7 GUCA1A 5.1 *RGS2 3.4
TNFAIP2 17.5 HLA-A 4.4 APBB2 3.2
IHH 16.6 *CHRDL1 3.7 BANK1 3.1
CARTPT 14.0 SASH1 3.5 *TCRA 3.0
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Table 3 Genes which are down regulated in large follicles with respect to small follicles† (Continued)
Other
LRRC17 7.1 TTN 3.6 MMD 3.1
STAC3 3.9 SEL1L3 3.6 BTNL1 3.1
LRRC1 3.8 CCDC3 3.2 TMIGD2 3.0
†(≥ 3-fold, P < 0.05) and categorised by function. Genes are listed in descending order of fold change in each category. Significance was determined by
Benjamini-Hochberg post-hoc test for multiple corrections following one way ANOVA.
*indicates genes determined from the Partek analysis based on the Affymetrix annotations which were not assigned identities by IPA.
Figure 4 Top ranked canonical pathways generated in Ingenuity Pathway Analysis (A), and enriched GO terms of interest (B),
determined by the GOEAST program, for a set of genes 3-fold differentially regulated with a Benjamini Hochberg False Discovery Rate
P < 0.05 between small and large follicles. A The bar chart on the left represents the percentage of genes from the data set that map to each
canonical pathway showing those which are up regulated (in red) and down regulated (in blue) in large with respect to small follicles. The
pathways are ranked from lowest (top) to highest (bottom) degree of association with genes from the data set by the P-value of a right tailed
Fishers exact t-test. The Benjamini-Hochberg test for multiple comparisons determined that these pathways all had –log P value = 0.23. B The bar
chart on the left represents the percentage of genes differentially regulated from the data set, which map to an enriched GO term of interest
classified as a biological process. The most significant terms from the analysis were not displayed as these were too general and not informative
in terms of specific function. The GO terms were ranked from lowest to highest degree of association with genes from our data set, by the
P-value calculated using the Benjamini-Yuketeli test for multiple comparisons (top to bottom in graph on right).
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Figure 5 The two top-ranked networks (A, B) determined for molecules mapped to the IPA database from a data set containing genes
differentially regulated between small and large follicles. Interactions between molecules are shown as explained in the legend, with focus
molecule symbols highlighted in color, based on up (red) or down (green) regulation in large follicles and of increasing intensity with degree of
fold change.
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An interesting subset of the signalling genes active in large
follicles is concerned with directional cell growth and
cellular processes, mainly through the SLIT (SLITRK1)/
roundabout or ROBO (ROBO1, ROBO2) and semaphorin
(SEMA6A)/plexin (PLXNB2, PLEXNC1) pathways (Table 2
and Figure 5A). ROBO1 and ROBO2, and SLITRK2 are
part of the SLIT-ROBO pathway, which acts as an
important repulsive cellular guidance mechanism to
control vascular and mesenchymal tissue development
[37]. Whilst follicles do not have a branching struc-
ture, during their growth they are expanding within
a stromal tissue, as branching ducts are required to
do, suggesting that the semaphorin (SEMA6A)/plexin(PLXNB2, PLEXNC1) pathway is important in the
process of follicle expansion. Another up-regulated gene
NOTCH1, can similarly affect cell polarity and tissue
structure [38].
In fact, these molecules are known to be present in fol-
licle development in the fetal ovary [39] and adult ovarian
follicle [40,41]. LRP8, an endocytosis and cholesterol
transport participant, was previously found to be more
highly expressed in large versus small antral follicles [42]
and in the dominant follicle compared with the subordin-
ate and preovulatory follicles [43]. LRP8 is also crucial for
binding ephrins, which are involved with directed growth
and cell migration [44]. Ephrin receptors, including A4
and their corresponding ligands, have been demonstrated
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stages. The activation of these genes and subsequent
axonal guidance pathways identified in our arrays indicate
the importance of polarity switching and cell rearrange-
ment as the follicle prepares for ovulation and luteinisa-
tion of granulosa cells. Ovulation requires that the follicle
and cumulus expand and the oocyte migrate to the point
of release facing the ovarian surface, which necessitates
coordinated signalling between mural and cumulus granu-
losa and the oocyte.
Protein trafficking
Molecules involved in protein trafficking constitute another
important group within our up-regulated data set (Table 1),
and some of these participate in cell signalling pathways
through the pleckstrin homology domain binding proteins
PLEKHA2, PLEKHB2, PLEKHG1 and PLEKHH3. PLE-
KHA2 is a participant in the phosphoinositidyl-3-phosphate
kinase (PI3K) signalling pathway which is sensitive to
superoxide production [46], possibly as a by-product of
steroidogenesis.
Transcription factors
As the follicle enlarges the granulosa cells mature and
we would expect major changes in the types of molecu-
lar pathways which are active in the granulosa cells. This
is reflected in the high number of transcriptional regula-
tors of developmental processes encoded by genes like
FOXP2, CREB3L2, JARID2, CITED1 and CITED2 which
are switched on in large follicles (Table 1). The cAMP-
responsive element binding protein (CBP) p300 interact-
ing transcriptional modulator CITED1, has been shown
to be activated by FSH treatment of in vitro matured
granulosa cells [47], and CITED2 encodes a factor which
competes with hypoxic inducible factor (HIF1α) for
CBPp300 [48], and is important for embryonic develop-
ment of neural tissue [49].
Cell growth
Many of the genes identified in this study encode proteins
responsible for growth and metabolism. Several of these are
known to be involved in follicular development and con-
firm previous studies, such as IGFBP-4 and-6, which were
found to be up regulated in granulosa cells isolated from
large follicles [50] (Table 1). Other genes such as chordin-
like 1, a BMP-4 antagonist [51], have not previously been
associated with follicular development.
Intercellular and matrix adhesion
A number of molecules which create intercellular interac-
tions and/or bind extracellular matrix are also encoded by
genes which are listed in Table 1. Nine extracellular matrix
genes were up regulated in large follicles, and encode pro-
teins including collagen types 4α1 (COL4A1) and 16α1(COL16A1), and laminin α1 (LAMA1), as well as the pro-
teoglycans, versican (VCAN), CSPG4 and syndecan 2
(SCD2) (Figure 5A). This group also contains the most
highly expressed gene from the entire list, TNFAIP6, al-
most 280-fold higher expressed in large follicles (Table 2
and Additional file 5: Figure S3). The up-regulated mole-
cules which bind matrix or stabilise intercellular attach-
ment, are represented by the tetraspanins 2 and 9
(TSPAN2, TSPAN9), the Rho GTPase activating proteins-
17 and −18 (ARHGAP17, ARHGAP18), and the well-
known cell surface antigens, integrin β5 (ITGB5) and
VCAM1, amongst others. Integrin β5 is expressed in ma-
ture follicles in the mouse [52] and it is known that integ-
rins bind extracellular matrix and can mediate cell
migration, replication or apoptosis [53]. VCAM1 expression
has not previously been associated with granulosa cells in
follicle development. It is generally expressed in endothelial
cells but can be expressed in other epithelia and promote
adhesion of circulating inflammatory cells [54], and thus
may also participate in the ovulatory process.
Proteolysis and inhibition
There are 13 up-regulated transcripts that encode
enzymes which collectively encompass a broad range of
proteolytic activities (Table 2) in large follicles. Two highly-
expressed transcripts are encoded by the serine protease
23 (PRSS23) and tissue plasminogen activator (PLAT)
genes. This group includes several members of the ADAM
family of metalloproteases: ADAM9, ADAM10, ADAM12
and ADAMTS4. Three well known protease inhibitor
genes, TIMP1, TIMP2 and SERPINA5, are also abundantly
expressed. Although it is known that ADAMTS1 plays a
role in matrix remodelling and is important for ovulation
in the mouse [55], horse [56] and human [57] and ADAM8
is regulated by progesterone and luteinising hormone [58],
there is little evidence to date concerning the function of
ADAM metalloproteases 9, 10 and 12 in the ovarian fol-
licle. These three proteases together are capable of degrad-
ing fibronectin and collagen IV, and shed Fas and kit
ligand from epithelial cells in vitro [59] and thus may regu-
late the breakdown of matrix and differentiation of granu-
losa cells prior to ovulation. The inhibitors of matrix
metalloproteases, TIMP 1 and 2 are also critical players in
the breakdown of matrix close to the time of ovulation
[60,61] and can promote progesterone synthesis. An im-
portant feature of future studies will be to comprehensively
map the spatio-temporal expression of these proteins in
the extracellular matrix, and determine the biological effect
of their accumulation.
Genes activated in small versus large follicles
Table 3 shows several important cytokine and receptor
genes which have lower expression in large follicles includ-
ing KIT, PDGFC (Figure 5B), FGFR2, F2RL2, IL33, IL20RA,
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genes of various functions include the developmental genes:
MEST (the most down regulated in large follicles, 28-fold),
IHH (also Figure 5B) and MYC, and also JAKMIP1, which
participates in cell polarisation.
Two of the genes mentioned before, KIT [62,63] and
AMH [64], are associated with follicle survival and matur-
ation. The imprinted gene MEST which is mesodermally
expressed in early embryos [65], is also strongly up regu-
lated in small follicles. This developmental gene has been
shown to be highly expressed in oocytes compared with
cumulus cells [66], but not necessarily throughout the
membrana granulosa. IHH, one of the hedgehog-signalling
family genes found here to be up regulated in small follicles,
has been shown to be necessary for proper egg chamber
formation in Drosophila [67], and is hormonally regulated
and associated with co-maturation of the theca interna in
the mammalian ovary [68]. Both IHH and MEST may be
necessary for the maintenance of an immature granulosa
cell phenotype in small follicles. Interestingly, a related
hedgehog family member Sonic Hedgehog Homolog (Shh)
has also been reported to be regulated by heparan sulphate
proteoglycan binding [69]. These molecules exist in abun-
dance within antral follicles in the form of syndecan and
glypican (cumulus cells) [70] and perlecan (between mural
granulosa cells) [27], and it is possible that they may play a
role at this stage of follicle development.
Upstream regulator analyses
IPA Upstream Regulator analysis was used to identify
upstream transcriptional regulators and the results are
shown in Table 4. The validity and usefulness of such
analyses is shown by the identification of known im-
portant pathways or molecules affecting follicle growth
or granulosa cell function such as the gonadotrophin/
protein kinase pathways (with identified upstream regula-
tors including chorionic gonadotrophin, follicle-stimulating
hormone, forskolin, 8-bromo cAMP, bucladesine which is a
cell permeable cAMP analogue, epidermal growth factor
pathway (ERBB2), renin angiotensin system (lorsartan
which is an inhibitor of the angiotensin Type II receptor),
oestradiol (tamoxifen;), leptin (LEPR), inhibin (INHBA),
GATA transcription factors (GATA6), , VEGF, retinoid ac-
tion (AGN194294 which is an RXR ligand), lipid metabol-
ism (APOE,) and the aryl hydrocarbon (AH) receptor
(tetrachlorodibenzodioxin).
Two molecules which have not been well studied in rela-
tion to follicular development appear to significantly alter
transcription in large follicles: XBP1 and STAT4 (Figure 6).
XBP1 is cleaved to an activated form under conditions of
endoplasmic reticulum stress and subsequently stimulates
the expression of a number of chaperones resulting in re-
moval of misfolded proteins and targets them for degrad-
ation [71]. It is predicted to be up regulated, and it ispossible that radical oxygen species generated by the ste-
roidogenic process may contribute to the misfolding of
proteins [72]. STAT4 is also predicted to be up regulated
in large follicles, and is a mediator of the interleukin −12
immune response [73,74], and further supports the in-
volvement of inflammatory processes detected within the
follicle at this time as indicated by the IPA and GO enrich-
ment analyses.
A new pathway or molecule identified by IPA Upstream
Regulator analyses is MGEA5 (meningioma expressed anti-
gen 5) which was down regulated in large follicles (Figure 6).
There is a diverse set of about 600 proteins known to be
post-translationally modified by the addition of O-linked
N-acetylglucosamine (O-GlcNAc) to their serine and
threonine residues by the action of the enzyme O-GlcNAc
transferase (OGT/Sxc) [75]. MGEA5 encodes beta-N-acet-
ylglucosaminidase (O-GlcNAcase), whose catalytic activity
removes O-GlcNAc from serine and threonine residues
in proteins [75]. This cycling of O-GlcNAc to post-
translationally modify proteins can therefore regulate the
activity of these proteins. O-linked glycosylation has been
observed in bovine cumulus cells and linked to the avail-
ability of nutrients for the fuel-sensing hexosamine bio-
synthetic pathway [76,77]. The hexosamine biosynthetic
pathway is sensitive to the levels of lipid, glucose and
amine which together supply components of O-GlcNAc.
Flux in nutrients thereby modulates protein activity by
flux in O-linked glycosylation of proteins. Down regula-
tion of MGEA5 in large follicles suggests that in small fol-
licles there is decreased O-linked glycosylation of proteins
and indeed increased O-linked glycosylation of proteins
has been observed to be negative for the success of oocyte
maturation [76,77].Conclusions
In conclusion, substantial changes occur in gene ex-
pression in granulosa cells as follicles enlarge from
small to large antral sizes. Gene expression becomes
less variable, and the processes of axonal guidance, im-
mune signalling and cell rearrangement were most af-
fected in large follicles. Some important networks were
associated with: (A) Notch, SLIT/ROBO and PI3K
signalling, and (B) ITGB5 and extracellular matrix sig-
nalling through extracellular signal related kinases
(ERKs). Upstream regulator genes which were pre-
dicted to be active in large follicles include STAT4 and
XBP1, whereas MGEA5 was predicted to be inhibited.
The latter encodes an enzyme that modifies the activity
of many target proteins, including those involved in
energy sensing, by removal of N-acetylglucosamine
from serine and threonine residues. By comparison,
developmental processes such as those stimulated by
KIT, IHH and MEST were most active in small follicles.
Table 4 Upstream regulators predicted to be activated or inhibited in large follicles compared with small follicles, using the 3-fold differentially-regulated data
set with FDR P < 0.05, on the basis of known interactions compiled in the IPA Upstream Regulator analysis




Target genes in the data set
Predicted activated molecules/genes
Tacrolimus Chemical drug 3.302 2.1×10-2 ABLIM1, ACTA1, CDK13, COL1A1, CYBB, FOS, ID3, IL33, MYC, PDCD4, PTGS2
STAT4 Transcription regulator 3.300 4.8×10-2 AKAP8L, ARFGAP3, ERRFI1, GLG1, IER3, MGARP, PYGL, RCN3, RNF128, SF3B1, WHSC1L1
Chorionic gonadotrophin Hormone 3.224 2.4×10-9 ABCB1, AKR1C3, CDH2, CLU, CYP11A1, CYP19A1, F2RL1, HSD3B2, IER3, IGFBP4, IL33, IL4R, INHBA,
ITGB5, LGALS3BP, LHCGR, MTPN, NPR3, NR5A2, NRP1, PFKFB3, PGR, PLAT, PPAP2B, PTGFR, PTGS2,
SFRP4, STAR, TIMP1, TNFAIP6, VCAN
XBP1 Transcription regulator 2.887 1.5×10-3 APBB2, APOA1, ARFGAP3, COPZ1, DERL1, EDEM2, GOLGA4, HERPUD1, HM13, HMOX1,
MYC, RCN3, RRT1, SEC63, VCAM1
FSH Hormone 2.759 1.8×10-4 ACTA1, BCL2L2, BMPR1A, BMPR2, CDH2, CITED1, CYP11A1, CYP19A1, FOS, GRK5, HSD3B2, IGFBP4,
INHBA, ITGB5, LHCGR, MAPK6, MYC, NOL3, PGR, PLAT, PTGS2, RPRM, STAR, TIMP1, TIMP2, TNFAIP6, TOB1
FOXO3 Transcription regulator 2.613 7.4×10-2 EIF4EBP1, FGFR2, GABARAPL1, GADD45B, IER3, MYC, SLC40A1, TXNIP
AGN194204 Chemical drug 2.550 2.4×10-3 ANAPC5, BZW2, CLIC4, FDFT1, IL4R, KLF6, MAN1A1, MYC, PDCD4, RCAN3, STIM1, STRA6, TIMP1
Forskolin Chemical toxicant 2.444 3.4×10-5 ACTA1, APOA1, ATP6V1A, CARTPT, CDH2, CLU, COL1A1, CYP11A1, CYP19A1, FOS, GRK5, HMOX1, HSD3B2,
ID2, ID3, IGFBP6, INHBA, ITGB5, LARGE, LHCGR, LTF, MYC, NOL3, NT5E, PGR, PLAT, PTGS2, PTHLH, RAB7A,
RPRM, SCG2, STAR, TIMP1, TNFAIP6, TXNIP, VCAN
INHBA Growth factor 2.389 3.2×10-2 CPNE8, CYP11A1, CYP19A1, DTNA, INHBA, LHCGR, PRPF38B, STAR, TIMP1
GATA6 Transcription regulator 2.377 5.6×10-3 BMPR2, CYP11A1, CYP19A1, HSD3B2, LHCGR, STAR
8-bromo-cAMP Chemical reagent 2.287 2.1×10-4 APOA1, CLU, CYP11A1, CYP19A1, FOS, HSD3B2, LHCGR, MYC, PGR, PLAT, PTGFR, PTGS2, STAR, TIMP1, TIMP2
Bucladesine Chemical toxicant 2.166 1.0×10-4 CDH2, CLU, CYP11A1, CYP19A1, ENPP1, ERRFI1, F3, FOS, GADD45B, HMOX1, HSD3B2, IGFBP6,
KIT, MYC, PTGS2, QSOX1, RGN, SCG2, STAR, TIMP1, TIMP2
Vegf Cytokine 2.008 2.6×10-4 ABCB1, ADAM10, ANGPT2, ANGPTL2, BMP2K, F3, GRK5, HES1, HMOX1, IGFBP4, INHBA, LPHN2,
LRP8, MYC, NOTCH1, NR5A2, NRP1, PPAP2B, PTGS2, PTHLH, TIMP1, TRIB2, VCAM1
Predicted inhibited molecules/genes
LEPR Transmembrane receptor −2.000 7.2×10-2 APOA1, APOA2, CARTPT, COL1A1, COL4A1, FOS, TIMP1
Losartan potassium Chemical drug −2.035 6.4×10-6 AQP1, COL1A1, CYBB, F3, FOS, GRK5, ITGB5, PTGS2, PTHLH, STAR, TIMP1, VCAM1
APOE Transporter −2.035 2.5×10-5 APOA1, CLU, COL1A1, CTSB, CYBB, F2R, F2RL1, F3, GPR77, GPX3, HMOX1, IGFBP6,
LRP8, MYO1B, NPNT, PPAP2B, PTGS2, TIMP1, VCAM1
Tetrachlorodi-benzodioxin Chemical toxicant −2.038 7.2×10-2 ABCB1, CYP11A1, CYP19A1, FOS, HES1, HMOX1, INSIG2, LHCGR,
MYC, MYO10, PTGFR, PTGS2, PTPN13, SLC40A1, SPOCK2, STAR
NR0B1 Ligand-dependent nuclear receptor −2.092 2.0×10-4 CYP11A1, CYP19A1, HSD3B2, NR5A2, STAR
Tamoxifen Chemical drug −2.241 4.5×10-3 CDH11, CLU, EPHX1, F2R, FHL2, FOS, HES1, IER3, IGFBP4, MYC, PGR, PTGS2, UGCG
MGEA5 Enzyme −2.500 1.9×10-3 ABLIM1, ACSS2, CMTM8, CREB3L2, FDFT1, FERMT2, IGFBP4, IL20RA, IL6R, ITGB5,
LPHN2, MYO10, PFKM, PPAP2B, TIMP1, TIMP2
ERBB2 Kinase −3.304 ACTA1, ADAM12, ANGPTL2, ATP6V1A, BEX2, CDH11, CHCHD10, CHST10, CLU, COL1A1, COL4A1, CUL1, CUL3,
DERL1, EIF4EBP1, F2R, FOS, GPX3, HES1, ID2, IGFBP4, IGFBP6, KIT, LAMC2, MAN1A1, MAOA, MFAP2, MYC, MYO10,
NDRG4, NEDD9, NOTCH1, NPNT, NRP1, PDCD4, PDLIM4, PFKFB3, PLAT, PTGS2, TGIF1, VCAN
*The bias-corrected z-score is used to infer the activation states of transcriptional regulators. It is calculated from the proportions of genes which are differentially regulated in an expected direction based on the
known interactions between the regulator and the genes present in the Ingenuity database. Those genes with a z-score greater or less than two are considered to be either activated or inhibited respectively.






















Figure 6 Two upstream regulators of interest, STAT4 (A) and XBP1 (B), which are predicted to be activated and one regulator, MGEA5 (C),
predicted to be inhibited in large follicles based on known interactions with genes in our data set by IPA. Interactions between molecules are
shown as explained in the legend, with focus molecule symbols highlighted in color, based on up (red) or down (green) regulation in large follicles and of
increasing intensity with degree of fold change. The suggested action of the central gene is indicated as up-(red) or down-(blue) regulating with the
degree of confidence increasing with color intensity. Arrowheads at the end of interactions indicate activation, whereas bars indicate inhibitory effects. The
unbroken arrows and the dashed arrows represent direct and indirect interactions respectively, between the genes and the upstream regulators.
Hatzirodos et al. BMC Genomics 2014, 15:24 Page 15 of 19
http://www.biomedcentral.com/1471-2164/15/24Methods
For these experiments bovine ovaries were collected as
pairs at a local abattoir in South Australia from non-
pregnant Bos taurus cows, within 20 min of slaughter and
transported to the laboratory on ice. Ovary pairs were
macroscopically examined for the presence of a corpus
luteum to exclude ovaries from non-cycling cows, and large
cystic follicles were discarded. Both small (≤ 5 mm in diam-
eter, n = 10) and large (> 12 mm, n = 4) follicles were se-
lected randomly from different animals. The follicles were
dissected from each ovary and the diameter measured with
the aid of an ocular micrometer. A portion of each follicle,
approximately 100 mm3, was removed and fixed in 2.5%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.25) for sub-
sequent classification of health or atresia, and granulosa
cells were collected from the remaining follicle wall. Only
healthy follicles were analysed in this study.Histological classification of follicles
Following fixation overnight, the portions of each ovary
were rinsed several times with buffer and post-fixed in2% (v/v) aqueous osmium tetroxide for 1 h at 4°C, as
described previously [78]. For light microscopic exam-
ination of all follicles, 1 μm-thick epoxy sections were
cut using glass knives and a Richert-Jung Ultracut E
ultramicrotome (Leica Microsystems Pty. Ltd., VIC,
Australia), stained with 1% (w/v) aqueous methylene
blue and examined using an Olympus BX50 micro-
scope (Olympus Australia Pty. Ltd, VIC, Australia).
Healthy and atretic follicles were identified as described
previously [18,19] and all healthy follicles, both large
and small, selected for the current experiments had no
dead or dying granulosa cells. The small follicle pheno-
type was sub-classified into two types, rounded or col-
umnar, based on the shape of the basally-situated
granulosa cells [79,80].Isolation of granulosa cells
Following removal of a portion of tissue for microscopic
examination, each follicle was transferred to a 35 mm
Petri dish containing 1.0 ml Hank’s balanced-salt solution
(HBSS) without calcium or magnesium. The granulosa cell
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pipette, previously modified by heat sealing the tip into a
rounded smooth surface. The HBSS containing the granu-
losa cells were centrifuged at 500 × g for 7 min at 4°C, the
medium was removed by aspiration and the cells washed
twice in phosphate-buffered saline. Finally the cells were
resuspended in RNAlater (Ambion, Austin, TX, USA),
and stored at −20°C until required.RNA isolation
Total RNA was extracted from the granulosa cells of 10
small and 4 large healthy follicles using RNeasy mini kits
(Qiagen). The concentration of the RNA was determined
by spectrophotometric measurement at 260 nm. For
each granulosa cell preparation, 5 μg of RNA was treated
with DNA-free (Ambion) according to the manufac-
turer’s instructions.Real time RT-PCR
Synthesis of cDNA and quantitative Reverse Transcriptase
Polymerase Chain Reaction (RT-PCR) using plasmid stan-
dards were performed as previously [81] and briefly de-
scribed here. Total RNA (500 ng) was reverse transcribed
with SuperScriptIII (Life Technologies, Carlsbad, Ca, USA)
using random hexamer primers (Geneworks, Thebarton,
SA, Australia) according to the manufacturer’s instructions.
The program Primer Express was used to design primers to
the bovine sequences of ribosomal 18S, CYP17A1 and
CYP19A1 (Table 5). An ABI Prism 7000 Sequence Detec-
tion System (Applied Biosystems, CA, USA) was used for
real time RT-PCR detection with SYBR Green (Eppendorf,
Hamburg, Germany) and 10 pmoles of forward and reverse
primers in a 20 μl reaction. The amplification conditions
are described in Table 5. Plasmid standards were generated
by cloning amplified products into pCR2.1-TOPO vector
(Life Technologies), then transformed into E. coli XL1 Blue
(Agilent Technologies), extracted and purified. These stan-
dards were quantitated by Absorbance at 260 nm and seri-
ally diluted over 3 logs then amplified together with the
diluted sample cDNA in the real time reaction to determine
quantities of RNA expressed as fg/ng 18S ribosomal RNA.Table 5 Primers and conditions used for quantitative RT-PCR
Target Primer sequences 5′-3′ Genbank accession nu
CYP19A1 Forward ggctatgtggacgtgttgacc NM_174305
Reverse tgagaaggagagcttgccatg
CYP17A1 Forward accatcagagaagtgctccgaa NM_174304
Reverse ccacaacgtctgtgcctttgt
18S Forward agaaacggctaccacatccaa DQ2224
Reverse cctgtattgttatttttcgtMicroarray profiling
Following confirmation of the quality of the RNA and
cDNA synthesis, hybridisations to GeneChip Bovine Gen-
ome Arrays (Affymetrix, CA, USA) and scanning were per-
formed according to Affymetrix protocols at the Australian
Genome Research Facility (Walter & Eliza Hall Institute of
Medical Research, Parkville, VIC, Australia) as previously
[82] and briefly described below. All samples were analysed
together using the same batch of arrays. In brief, the start-
ing amount of total RNA for each probe preparation varied
between 2 to 5 μg. First-strand cDNA synthesis was per-
formed using a T7-linked oligo-dT primer, followed by sec-
ond strand synthesis. In vitro transcription reactions were
performed in batches to generate biotinylated cRNA tar-
gets, which were subsequently chemically fragmented at
95°C for 35 min. Twenty μg of the fragmented, biotinylated
cRNA was hybridised at 45°C for 16 h to Affymetrix Gene-
Chip Bovine Genome Arrays, which contained 24,128
probe sets representing over 23,000 transcripts and vari-
ants, including 19,000 UniGene clusters. The arrays were
then washed and stained with streptavidin-phycoerythrin
(final concentration 10 μg/ml). Signal amplification was
achieved by using a biotinylated anti-streptavidin antibody.
The array was then scanned according to the manufac-
turer’s instructions. The scanned images were inspected for
the presence of any defect on the array.
Data normalisation and analyses
To minimise discrepancies due to variables such as sam-
ple preparation, hybridisation conditions, staining, or
array lot, the raw expression data was normalised using
the RMA background correction (Robust Multi-array
average [83]) with quantile normalisation, log base 2
transformation and mean probe set summarisation with
adjustment for GC content and performed in Partek
Genomics Suite Software version 6.5 (Partek Incorpo-
rated, St Louis, MO, USA). All samples sent for analysis
passed all quality controls during analysis. The arrays
were analysed as part of a larger set of CEL files which
additionally included samples of granulosa RNA from 5
atretic follicles as discussed elsewhere [82]. For initial
statistical analysis, the data were first subjected to Prin-
cipal Component Analysis (PCA, based on the methodmber PCR reaction and conditions
2 min 50C, 10 min 95C, 40 × cycles of 15 s 95C and 60 s 60C
2 min 50C, 10 min 95C, 40 × cycles of 15 s 95C and 60 s 60C
2 min 50C, 10 min 95C, 40 × cycles of 15 s 95C and 60 s 60C
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http://www.biomedcentral.com/1471-2164/15/24of [84]) and hierarchical clustering analysis to compare
the gene expression patterns of the arrays in terms of
our classification. Hierarchical clustering was performed
using the Euclidian algorithm for dissimilarity with aver-
age linkage. The expression data were analysed by
ANOVA using method of moments estimation [85] with
post-hoc FDR test for multiple comparisons. The fold
change in expression for each gene was based on the
non log-transformed values after correction and normal-
isation. A differentially-expressed gene data set was
imported into IPA and genes mapped against the In-
genuity Knowledge Base for network and pathway ana-
lysis. These differentially-expressed genes were further
annotated and classified based on the GO consortium
annotations from the GO Bos taurus database (2010/02/
24) [86] using GOEAST [87]). The background for the
gene enrichment analyses in IPA and GOEAST was the
whole array. Statistical association for mapping of genes
to functions and pathways in IPA was conducted using a
Fisher’s right tailed t-test and similarly ranking of map-
ping to GO terms in GOEAST was accomplished by the
Benjamini-Yuketeli method. Expression data were also
exported to Excel and used to generate size-frequency
distributions of the coefficient of variation for each
probe set for small and large follicles. We also used IPA
Upstream Regulator analysis to identify upstream tran-
scriptional regulators by Fisher’s exact t-test. The ana-
lytical outcome is based upon prior knowledge of
expected effects between transcriptional regulators and
target genes stored in the Ingenuity Knowledge Base.
The microarray CEL files, normalised data and experi-
mental information have been deposited in the GEO
database under series record GSE39589.
Additional files
Additional file 1: Figure S1. Unsupervised hierarchical clustering across
all probe sets (n = 24,182) for 14 arrays using the Euclidian dissimilarity
algorithm method with average linkage in Partek. The heatmap
represents the distribution of normalised signal intensity, grouping by
pattern similarity for both probe set and array. The R columns represent
the rounded granulosa cells and the C columns represent the columnar
granulosa cell arrays.
Additional file 2: Figure S2. Plots of coefficients of variation (CV)
versus their frequency for granulosa cell cDNA hybridised to Bovine
Genome Affymetrix Expression arrays across replicate samples per gene
for small (n = 10) and large follicles (n = 4). The 50% most highly
expressed genes, representing half of all probe sets (n = 12,064) were
used in these analyses. 2 fold and 3 fold represent all probe sets which
were 2-fold (n = 1809) or 3-fold (n = 598) differentially regulated between
small and large follicles in Partek.
Additional file 3: Table S1. The total number of probe sets (758)
which were 3-fold differentially regulated with a Benjamini-Hochberg
FDR multiple correction of P < 0.05 between large and small healthy
follicles listed in alphabetical order by gene symbol.
Additional file 4: Figure S3. The complete canonical Axonal Guidance
Signalling pathway as presented in IPA showing which genes map from
the 3-fold differentially-expressed dataset with a Benjamini-Hochberg FDRmultiple correction P < 0.05 between large and small healthy follicles.
Genes which are up regulated in large are indicated in red, and those
which are down regulated are green, with the degree of fold difference
commensurate with the color intensity.
Additional file 5: Figure S4. The complete canonical IL-6 signalling
pathway as presented in IPA showing which genes map from the 3-fold
differentially-expressed dataset with a Benjamini-Hochberg FDR multiple
correction P < 0.05 between small and large healthy follicles. Genes which
are up-regulated in large are indicated in red, and those which are
down-regulated are green, with the degree of fold difference
commensurate with the color intensity.
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